Target intelligence / Profile preview

Mycobacterium tuberculosis membrane and energy metabolism

Molecular classification
Enzyme, Transporter, Other
01

Overview

Mycobacterium tuberculosis membrane and energy metabolism encompasses the essential biochemical pathways and structural components required for the bacterium to generate ATP and maintain its electrochemical membrane potential (Cook et al., 2017, Nature Reviews Microbiology). This system is primarily centered on the oxidative phosphorylation machinery, including the electron transport chain (ETC) and the F1F0-ATP synthase complex (Bald et al., 2017, FEMS Microbiology Reviews). Unlike many other bacteria, Mtb is an obligate aerobe that relies heavily on these respiratory processes for survival, even during periods of dormancy or persistence within host granulomas (Gengenbacher & Kaufmann, 2012, FEMS Microbiology Reviews). Therapeutic agents targeting this system, such as bedaquiline, work by inhibiting specific enzymes like ATP synthase or the cytochrome bc1-aa3 complex, thereby depleting the energy reserves of the pathogen (Andries et al., 2005, Science). Because these metabolic processes are distinct from those in human mitochondria, they represent highly selective and potent targets for treating both drug-sensitive and multi-drug-resistant tuberculosis (Koul et al., 2008, Nature). The maintenance of the proton motive force across the membrane is also a critical aspect of this target area, as it drives various secondary active transport processes essential for viability (Rao et al., 2008, Journal of Bacteriology).

Other names
Mtb bioenergeticsMtb oxidative phosphorylationMtb electron transport chainMtb respiratory chain
02

Mechanism of action

Inhibition of ATP synthase, inhibition of the cytochrome bc1-aa3 complex (QcrB), and disruption of the electrochemical gradient across the plasma membrane (Andries et al., 2005; Pethe et al., 2013).

03

Biological functions

ATP synthesisCellular respirationProton motive force maintenanceElectron transportOther
04

Disease associations

Infection
05

Safety considerations

QT interval prolongationHepatotoxicityDrug-drug interactions (e.g., with CYP3A4 inducers/inhibitors)Emergence of resistance
06

Interacting drugs

Bedaquiline

5 more in the full profile.

07

Biomarkers

Sputum culture conversionTime to positivity (TTP)Mycobacterial loadLipoarabinomannan (LAM) levels

Beyond the preview

Go deeper on Mycobacterium tuberculosis membrane and energy metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis membrane and energy metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call